Sanara Medtech Inc
SMTI24.527USD
+0.367+1.52%
交易中 （美东）报价延迟15分钟
218.38M总市值
亏损市盈率 TTM
关于 Sanara Medtech Inc 公司
Sanara Medtech Inc. 是一家医疗技术公司，专注于开发和商业化变革性技术，以改善临床结果并降低外科、慢性伤口和皮肤护理市场的医疗支出。该公司销售多种用于外科和慢性伤口护理的产品，并有多种产品正在研发中。其外科产品 CellerateRX Surgical、TEXAGEN、BiFORM、ACTIGEN、ALLOCYTE、ALLOCYTE Plus 高级活骨基质 (ALLOCYTE Plus)、BIASURGE、FORTIFY TRG 组织修复移植物 (FORTIFY TRG) 和 FORTIFY FLOWABLE 细胞外基质 (FORTIFY FLOWABLE) 被用于一系列外科专业，以帮助促进患者康复并降低并发症风险。 CellerateRX 外科产品、TEXAGEN 产品、FORTIFY TRG 和 FORTIFY FLOWABLE 用于心胸外科、结直肠外科、普通外科、手部、头颈部、高危妇产科、莫氏手术、神经外科等专业领域。
公司简介
公司代码SMTI
公司名称Sanara Medtech Inc
上市日期Apr 07, 1994
CEOMr. Suresh V. (Sam) Muppalla
员工数量141
证券类型Ordinary Share
年结日Apr 07
公司地址1200 Summit Avenue
城市FORT WORTH
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编76102
电话18175292300
网址https://sanaramedtech.com/
公司代码SMTI
上市日期Apr 07, 1994
CEOMr. Suresh V. (Sam) Muppalla
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
64.04K
--
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Commercial Officer
President, Chief Commercial Officer
61.29K
-7.44%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
64.04K
--
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Commercial Officer
President, Chief Commercial Officer
61.29K
-7.44%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Soft tissue repair products
20.53M
87.62%
Bone fusion products
2.90M
12.38%
暂无数据
业务
地区
业务USD
名称
营收
占比
Soft tissue repair products
20.53M
87.62%
Bone fusion products
2.90M
12.38%
股东统计
更新时间: 5月29日 周四
更新时间: 5月29日 周四
持股股东
股东类型
持股股东
持股股东
占比
FA Sanara, L.L.C.
39.51%
Stuckert (James W)
10.88%
Tall Pines Capital LLC
5.77%
Howell (Solomon Oden Jr)
5.52%
The Vanguard Group, Inc.
2.21%
Other
36.11%
持股股东
持股股东
占比
FA Sanara, L.L.C.
39.51%
Stuckert (James W)
10.88%
Tall Pines Capital LLC
5.77%
Howell (Solomon Oden Jr)
5.52%
The Vanguard Group, Inc.
2.21%
Other
36.11%
股东类型
持股股东
占比
Corporation
45.28%
Individual Investor
20.06%
Investment Advisor
6.63%
Investment Advisor/Hedge Fund
3.35%
Research Firm
0.77%
Hedge Fund
0.56%
Bank and Trust
0.12%
Pension Fund
0.11%
Insurance Company
0.02%
Other
23.09%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
125
6.84M
76.91%
+482.04K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
2023Q1
75
5.66M
71.11%
-305.86K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
FA Sanara, L.L.C.
3.51M
39.51%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.88%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.77%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.52%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
196.47K
2.21%
-4.33K
-2.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
193.22K
2.17%
-3.99K
-2.02%
Mar 31, 2025
Stonebridge Wealth Management, LLC
100.06K
1.13%
+100.06K
--
Sep 30, 2024
Geode Capital Management, L.L.C.
88.75K
1%
+881.00
+1.00%
Mar 31, 2025
Nixon (Ronald T)
64.04K
0.72%
--
--
Apr 11, 2025
State Street Global Advisors (US)
63.28K
0.71%
-900.00
-1.40%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
查看更多
WisdomTree US SmallCap Fund
占比0.03%
iShares Micro-Cap ETF
占比0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
ProShares UltraPro Russell2000
占比0%
Dimensional US Core Equity 1 ETF
占比0%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
Global X Russell 2000 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
